Literature DB >> 24751481

APC/C is an essential regulator of centrosome clustering.

Konstantinos Drosopoulos1, Chan Tang2, William C H Chao2, Spiros Linardopoulos3.   

Abstract

Centrosome amplification has been extensively associated with cancer. Cancer cells with extra centrosomes have the ability to cluster the extra centrosomes and divide in a bipolar fashion. Although a number of proteins have been shown to be involved in centrosome clustering, a mechanistic understanding of how this process is coordinated is not yet well defined. Here, to reveal regulators of centrosome clustering, we perform small interfering RNA (siRNA) screens with multiple assay readouts in a human isogenic cellular model. We find that APC/C activity is essential for centrosome clustering. We show that the motor kinesin Eg5 is a substrate of APC/C-CDH1, and that inhibition of APC/C results in stabilization of Eg5. Increased Eg5 protein levels disturb the balance of forces on the spindle and prevent centrosome clustering. This process is completely reversed after a short treatment with the Eg5 inhibitor, monastrol. These data advance our understanding of the regulation of centrosome clustering.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24751481     DOI: 10.1038/ncomms4686

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  27 in total

Review 1.  Ubiquitin, the centrosome, and chromosome segregation.

Authors:  Ying Zhang; Paul J Galardy
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

2.  The role of APC/C(Cdh1) in replication stress and origin of genomic instability.

Authors:  C Greil; J Krohs; D Schnerch; M Follo; J Felthaus; M Engelhardt; R Wäsch
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

3.  Mechanics of Multicentrosomal Clustering in Bipolar Mitotic Spindles.

Authors:  Saptarshi Chatterjee; Apurba Sarkar; Jie Zhu; Alexei Khodjakov; Alex Mogilner; Raja Paul
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

4.  Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability.

Authors:  Kuntal De; Treg M Grubb; Abigail A Zalenski; Kayla E Pfaff; Debjani Pal; Shubhra Majumder; Matthew K Summers; Monica Venere
Journal:  Mol Cancer Res       Date:  2019-04-29       Impact factor: 5.852

5.  The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.

Authors:  Monica Venere; Craig Horbinski; James F Crish; Xun Jin; Amit Vasanji; Jennifer Major; Amy C Burrows; Cathleen Chang; John Prokop; Quilian Wu; Peter A Sims; Peter Canoll; Matthew K Summers; Steven S Rosenfeld; Jeremy N Rich
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

Review 6.  The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy.

Authors:  Christine Greil; Monika Engelhardt; Ralph Wäsch
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

Review 7.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

8.  Fbxo30 Regulates Mammopoiesis by Targeting the Bipolar Mitotic Kinesin Eg5.

Authors:  Yan Liu; Yin Wang; Zhanwen Du; Xiaoli Yan; Pan Zheng; Yang Liu
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

9.  The Insulin Receptor Adaptor IRS2 is an APC/C Substrate That Promotes Cell Cycle Protein Expression and a Robust Spindle Assembly Checkpoint.

Authors:  Sandhya Manohar; Qing Yu; Steven P Gygi; Randall W King
Journal:  Mol Cell Proteomics       Date:  2020-06-18       Impact factor: 5.911

10.  CSAG1 maintains the integrity of the mitotic centrosome in cells with defective p53.

Authors:  Hem Sapkota; Jonathan D Wren; Gary J Gorbsky
Journal:  J Cell Sci       Date:  2020-05-27       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.